Milbank LLP represented the lenders in connection with the provision of $350 million term loan facilities for LivaNova PLC (Nasdaq: LIVN) (“LivaNova”). The proceeds of the facilities were used to repay in full a $220 million bridge facility as well as for other general corporate purposes.
Headquartered in London, LivaNova is a global medical device company focused on the design, development, manufacturing and sales of innovative products and therapies.
The Milbank team was led by New York-based Global Leveraged Finance partner Lauren Hanrahan with assistance from associates Gabrielle Paolini, Mitch Cooper and Michael Mey.
